Solid-core and hollow magnetic nanostructures: Synthesis, surface modifications and biological applications

Bioelectrochemistry

Volumn 93, Issue , 2013, Pages 2-14

  Nieciecka, Dorota ^a   Nawara, Krzysztof ^a   Kijewska, Krystyna ^a   Nowicka, Anna M ^a   Mazur, Maciej ^a   Krysinski, Pawel ^a  

^a UNIVERSITY OF WARSAW   (Poland)

Author keywords

Doxorubicin; Magnetic nanoparticles; Polymer microcapsules

Indexed keywords

DRUG DELIVERY; ENCAPSULATION; NANOSTRUCTURED MATERIALS; POLYPYRROLES;

BIOLOGICAL APPLICATIONS; DOXORUBICIN; MAGNETIC IRON OXIDE NANOPARTICLES; MAGNETIC NANO-PARTICLES; MAGNETIC NANOSTRUCTURES; NANOSTRUCTURED PARTICLES; POLYMER MICROCAPSULES; POLYMERIC CAPSULES;

POLYMERS;

DOXORUBICIN; IRON OXIDE; MAGNETIC IRON OXIDE NANOPARTICLE; MAGNETIC NANOPARTICLE; NANOCAPSULE; POLYPYRROLE; UNCLASSIFIED DRUG;

ARTICLE; CYCLIC POTENTIOMETRY; DRUG DELIVERY SYSTEM; LIPID MONOLAYER; MICROCAPSULE; MICROVASCULATURE; NANOENCAPSULATION; POLYMERIZATION; QUARTZ CRYSTAL MICROBALANCE; SURFACE PROPERTY; SYNTHESIS;

THERA;

DOXORUBICIN; MAGNETIC NANOPARTICLES; POLYMER MICROCAPSULES;

CHEMISTRY TECHNIQUES, SYNTHETIC; DOXORUBICIN; MAGNETS; NANOSTRUCTURES; NANOTECHNOLOGY; SURFACE PROPERTIES;

EID: 84882885624     PISSN: 15675394     EISSN: 1878562X     Source Type: Journal    
DOI: 10.1016/j.bioelechem.2012.06.001     Document Type: Article

References (67)

1. Mazur M. Preparation of surface-supported polypyrrole capsules using a solidified droplets template approach. J. Phys. Chem. B 2009, 113:728-733.
2. Mazur M. Polypyrrole containers grown on oil microdroplets: encapsulation of fluorescent dyes. Langmuir 2008, 24:10414-10420.
3. Mazur M. Preparation of three-dimensional polymeric structures using gas bubbles as templates. J. Phys. Chem. C 2008, 112:13528-13534.
4. Gewirtz D.A. A critical evaluation of the mechanism of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem. Pharmacol. 1999, 57:727-741.
5. Rahman A.M., Yusuf S.W., Ewer M.S. Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation. Int. J. Nanomed. 2007, 2:567-583.
6. Batist C. Cardiac safety of liposomal anthracyclines. Cardiovasc. Toxicol. 2007, 7:72-74.
7. D'Arpa P., Liu L.F. Topoisomerase-targeting antitumor drugs. Biochim. Biophys. Acta 1989, 989:163-177.
8. Chaires J.B., Herrera J.E., Waring M. Preferential binding of daunomycin to 5'atcg and 5'atgc sequences revealed by footprinting titration experiments. Biochemistry 1990, 29:6145-6153.
9. Capanico G., Zunino F. Molecular Basis of Specificity in Nucleic Acid-Drug Interactions 1990, 167-176. Kluwer Academic, The Netherlands. B. Pullman, J. Jortner (Eds.).
10. Duguet M., Lavenot C., Harper F., Mirambeau G., de Recondo A.M. DNA topoisomerases from rat-liver - physiological variations. Nucleic Acids Res. 1983, 11:1059-1075.
11. Singha B.K., Mimnaugh E.G. Free radicals and anticancer drug resistance; oxygen free radicals in the mechanisms of drug cytotoxicity and resistance by certain tumors. Free Radic. Biol. Med. 1990, 8:567-581.
12. Dupou-Cezanne L., Santereau A.M., Tocanne J.F. Localization of adriamycin in model and natural membranes - influence of lipid molecular packing. Eur. J. Biochem. 1989, 181:695-702.
13. Gallois L., Fiallo M., Laigle A., Priebe W., Garnier-Suillerot A. The overall partitioning of anthracyclines into phosphatidyl-containing model membranes depends neither on the drug charge nor the presence of anionic phospholipids. Eur. J. Biochem. 1996, 241:879-887.
14. De Wolf F.A., Staffhorst R.W.H.M., Smits H.P., Onwenzen M.F., de Krujiff B. Role of anionic phospholipids in the interaction of doxorubicin and plasma-membrane vesicles - drug-binding and structural consequences in bacterial systems. Biochemistry 1993, 32:6688-6695.
15. De Wolf F.A., Maliepaard M., Van Dorsten F., Berghuis I., Nicolay K., de Krujiff B. Comparable interaction of doxorubicin with various acidic phospholipids results in changes of lipid order and dynamics. Biochim. Biophys. Acta 1991, 1096:67-80.
16. Nieciecka D., Krysinski P. Interactions of doxorubicin with self-assembled monolayer-modified electrodes: electrochemical, surface plasmon resonance (SPR), and gravimetric studies. Langmuir 2011, 27:1100-1107.
17. Zhang J., Rosilio V., Goldmann M., Boissonnade M.M., Baszkin A. Adsorption of glucose oxidase into lipid monolayers. Effect of lipid chain lengths on the stability and structure of mixed enzyme/phospholipid films. Langmuir 2000, 16:1226-1232.
18. Dynarowicz-Ła{ogonek}tka P., Dhanabalan A., Oliveira O.N. Modern physicochemical research on Langmuir monolayers. Adv. Colloid Interface Sci. 2001, 91:221-293.
19. Stern H.A., Feller S.E. Calculation of the dieletric permittivity profile nonuniform system: application to a lipid bilayer simulation. J. Chem. Phys. 2003, 118:3401-3412.
20. Heywang C., Saint-Pierre-Chazalet M., Masson M., Bolard J. SERR study of the interaction of anthracyclines with mono- and bilayers of charged phospholipids. Langmuir 1997, 13:5634-5643.
21. Sauerbrey G. Verwendung von schwingquarzen zur wagung dunner schichten und zur mikrowagung. Z. Phys. 1959, 155:206-222.
22. Zawisza I., Xiaomin B., Lipkowski J. Potential-driven structural changes in Langmuir-Blodgett DMPC bilayers determined by in situ spectroelectrochemical PM IRRAS. Langmuir 2007, 23:5180-5194.
23. Kycia A.H., Wang J., Merrill A.R., Lipkowski J. Atomic force microscopy studies of a floating-bilayer lipid membrane on a Au(111) surface modified with a hydrophilic monolayer. Langmuir 2011, 27:10867-10877.
24. Sek S., et al. Molecular resolution imaging of an antibiotic peptide in a lipid matrix. J. Am. Chem. Soc. 2009, 131:6439-6444.
25. Krysinski P., Blanchard G.J. Synthesis and characterization of amphiphilic biomimetic assemblies at electrochemically active surfaces. Langmuir 2003, 19:3875-3882.
26. Oliveira-Brett A.M., Piedade J.A.P., Chiorcea A.M. Anodic voltammetry and AFM imaging of picomoles of adriamycin adsorbed onto carbon surfaces. J. Electroanal. Chem. 2002, 538-539:267-276.
27. Vacek J., Havran L., Fojta M. Ex situ voltammetry and chronopotentiometry of doxorubicin at a pyrolytic graphite electrode: redox and catalytic properties and analytical applications. Electroanalysis 2009, 19:2139-2144.
28. Amatore C., Saveant J.M., Tessier D. Charge-transfer at partially blocked surfaces - a model for the case of microscopic active and inactive sites. J. Electroanal. Chem. Interfacial Electrochem. 1983, 147:39-51.
29. Krysinski P., Brzostowska-Smolska M. Three-probe voltammetric characterisation of octadecanethiol self-assembled monolayer integrity on gold electrodes. J. Electroanal. Chem. 1997, 424:61.
30. Zebrowska A., Krysinski P., Łotowski Z. Electrochemical studies of blocking properties of solid supported tethered lipid membranes on gold. Bioelectrochemistry 2002, 56:179-184.
31. Krysinski P., Brzostowska-Smolska M., Mazur M. Incorporation of redox molecules into the monolayer modified electrodes. Mater. Sci. Eng. C 1999, 8-9:551-557.
32. Komorsky-Lovric S. Redox kinetics of adriamycin adsorbed on the surface of graphite and mercury electrodes. Bioelectrochemistry 2006, 69:82-87.
33. Komorsky-Lovric S., Lovric M. Electrode reaction of adriamycin interpreted as two consecutive electron transfers with stabilization of the intermediate. Collect. Czech. Chem. Commun. 2007, 72:1398-1406.
34. Hahn Y., Lee H.Y. Electrochemical behavior and square wave voltammetric determination of doxorubicin hydrochloride. Arch. Pharm. Res. 2004, 27:31-34.
35. Yau H.C.M., Chan H.L., Yang M. Electrochemical properties of DNA-intercalating doxorubicin and methylene blue on n-hexadecyl mercaptan-doped 5'-thiol-labeled DNA-modified gold electrodes. Biosens. Bioelectron. 2003, 18:873-879.
36. Brzozowska M., Krysinski P. Synthesis and functionalization of magnetic nanoparticles with covalently bound electroactive compound doxorubicin. Electrochim. Acta 2009, 54:5065-5070.
37. Yan W., Shen X.C., Zhang Z.L., Chen C., Pang D.W. Electrochemical behavior of daunorubicin at DNA-MWCNT bioconjugates modified glassy carbon electrodes. Anal. Lett. 2005, 38:2579-2795.
38. Speelmans G., Staffhorst R.W.H.M., de Kruijff B. The anionic phospholipid-mediated membrane interaction of the anti-cancer drug doxorubicin is enhanced by phosphatidylethanol-amine compared to other zwitterionic phospholipids. Biochemistry 1997, 36:8657-8662.
39. Bhasakar S., Tian F., Stoeger T., Kreyling W., de la Fuente J.M., Grazu V., Borm P., Estrada G., Ntziachristos V., Razansky D. Multifunctional nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier; perspectives on tracking and neuroimaging. Part. Fibre Toxicol. 2010, 7:3.
40. Shubayev V.I., Pisanic T.R., Jin S. Magnetic nanoparticles for theragnostics. Adv. Drug Deliv. Rev. 2009, 61:467-477.
41. Laurent S., Forge D., Port M., Roch A., Robic C., Vander Elst L., Muller R.N. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem. Rev. 2008, 108:2064-2110.
42. Sun C., Lee J.S.H., Zhang M. Magnetic nanoparticles in MR imaging and drug delivery. Adv. Drug Deliv. Rev. 2008, 60:1252-1265.
43. Kievit F.M., Zhang M. Surface engineering of iron oxide nanoparticles for targeted cancer therapy. Acc. Chem. Res. 2011, 44:853-862.
44. Kim B., Han G., Toley B.J., Kim C.K., Rotello V.M., Forbes N.S. Tuning payload delivery in tumour cylindroids using gold nanoparticles. Nat. Nanotechnol. 2010, 5:8649-8652.
45. Majewski P., Krysinski P. Synthesis, surface modifications, and size-sorting of mixed nickel-zinc ferrite colloidal magnetic nanoparticles. Chem. Eur. J. 2008, 14:7961-7968.
46. Nowicka A., Kowalczyk A., Donten M., Krysinski P., Stojek Z. Influence of a magnetic nanoparticle as a drug carrier on the activity of anticancer drugs: interactions of double stranded DNA and doxorubicin modified with a carrier. Anal. Chem. 2009, 81:7474-7483.
47. Butoescu N., Seemayer C., Palmer G., Guerne P.A., Gabay C., Doelker E., Jordan O. Magnetically retainable microparticles for drug delivery to the joint: efficacy studies in an antigen-induced arthritis model in mice. Arthritis Res. Ther. 2009, 11:R72.
48. Lattuada M., Hatton T.A. Functionalization of monodisperse magnetic nanoparticles. Langmuir 2007, 23:2158-2168.
49. Kumar S., Ravikumar C., Bandyopadhyaya R. State of dispersion of magnetic nanoparticles in an aqueous medium: experiments and Monte Carlo simulation. Langmuir 2010, 26:18320-18330.
50. Prasad N.K., Gohri V., Bahadur D. Nanoparticles of pure and substituted maghemites. J. Nanosci. Nanotechnol. 2011, 11:2710-2716.
51. Tewes F., Munnier E., Antoon B., Ngaboni Okassa L., Cohen-Jonathan S., Marchais H., Douziech-Eyrolles L., Soucé M., Dubois P., Chourpa I. Comparative study of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods. Eur. J. Pharm. Biopharm. 2007, 66:488-492.
52. Li X., Hirsh D.J., Cabral-Lilly D., Zirkel A., Gruner S.M., Janoff A.S., Perkins W.R. Doxorubicin physical state in solution and inside liposomes loaded via a pH gradient. Biochim. Biophys. Acta, Biomembr. 1998, 1415:23-40.
53. Vidal-Vidal J., Rivas J., Lopez-Quintela M.A. Synthesis of monodisperse maghemite nanoparticles by the microemulsion method. Colloids Surf. A: Physicochem. Eng. Aspects 2006, 288:44-51.
54. Nawara K., Romiszewski J., Kijewska K., Szczytko J., Twardowski A., Mazur M., Krysinski P. Adsorption of doxorubicin onto citrate-stabilized magnetic nanoparticles. J. Phys. Chem. C 2012, 116:5598-5609.
55. Kubacka D., Krysiński P., Blanchard G.J., Stolarski J., Mazur M. Toluene-filled polypyrrole microvessels: entrapment and dynamics of encapsulated perylene. J. Phys. Chem. B 2010, 114:14890-14896.
56. Kisiel A., Mazur M., Kuśnieruk S., Kijewska K., Krysiński P., Michalska A. Polypyrrole microcapsules as a transducer for ion-selective electrodes. Electrochem. Commun. 2010, 12:1568-1571.
57. Mazur M., Krywko-Cendrowska A., Krysiński P., Rogalski J. Encapsulation of laccase in a conducting polymer matrix: a simple route towards polypyrrole microcontainers. Synth. Met. 2009, 159:1731-1738.
58. Liu J., Zhang Y., Wang C., Xu R., Chen Z., Gu N. Magnetically sensitive alginate-templated polyelectrolyte multilayer microcapsules for controlled release of doxorubicin. J. Phys. Chem. C 2010, 114:7673-7679.
59. Thomas C.R., Ferris D.P., Lee J.H., Choi E., Cho M.H., Kim E.S., Stoddart J.F., Shin J.S., Cheon J., Zink J.I. Noninvasive remote-controlled release of drug molecules in vitro using magnetic actuation of mechanized nanoparticles. J. Am. Chem. Soc. 2010, 132:10623-10625.
60. Gorin D.A., Portnov S.A., Inozemtseva O.A., Lulkinska Z., Yashchenok A.M., Pavlov A.M., Skirtach A.G., Moehwald H., Sukhorukov G.B. Magnetic/gold nanoparticle functionalized biocompatible microcapsules with sensitivity to laser irradiation. Phys. Chem. Chem. Phys. 2008, 10:6899-6905.
61. Han B., Shen B., Wang Z., Shi M., Li H., Peng C., Zhao Q., Gao C. Layered microcapsules for daunorubicin loading and release as well as in vitro and in vivo studies. Polym. Adv. Technol. 2008, 19:36-46.
62. Kijewska K., Blanchard G.J., Szlachetko J., Stolarski J., Kisiel A., Michalska A., Maksymiuk K., Pisarek M., Majewski P., Krysinski P., Mazur M. Photopolymerized polypyrrole microvessels. Chem. Eur. J. 2012, 18:310-320.
63. Bidan G., Jarjayes O., Fruchart J.M., Hannecart E. New nanocomposites based on tailor dressed magnetic particles in a polypyrrole matrix. Adv. Mater. 1994, 6:152-155.
64. Han B., Shen B., Wang Z., Shi M., Li H., Peng C., Zhao Q., Gao C. Layered microcapsules for daunorubicin loading and release as well as in vitro and in vivo studies. Polym. Adv. Technol. 2008, 19:36-46.
65. Gao Z.G., Fain H.D., Rapoport N. Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound. J. Control. Release 2005, 102:203-222.
66. Park J.H., von Maltzahn G., Ong L.L., Centrone A., Hatton T.A., Ruoslahti E., Bhatia S.N., Sailor M. Cooperative nanoparticles for tumor detection and photothermally triggered drug delivery. Adv. Mater. 2009, 21:1-6.
67. Deckers R., Moonen C.T.W. Ultrasound triggered, image guided, local drug delivery. J. Control. Release 2010, 148:25-33.